Bulldog Investors’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Bulldog Investors’s Portfolio CYT Stock Details CYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200,000	Closed	-$608K	–	195
2023 Q4	$608K	Hold	200,000	–	–	0.2%	84
2023 Q3	$568K	Buy	+200,000	New	+$551K	0.2%	90

Other funds holding CYT

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BFO

Boston Family Office Boston, Massachusetts $1.65B AUM 18.1% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Bulldog Investors's CYT Position: Q1 2024 in Review

Bulldog Investors sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q1 2024, closing a stake of 200,000 shares — an estimated $608K sold.

Bulldog Investors first reported a position in CYT in Q3 2023 and held it in 2 quarters. The position peaked at $608K in Q4 2023. 4 funds tracked by Wall St. Rank hold CYT as of Q1 2024.

Bulldog Investors reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Bulldog Investors sold 200,000 Cyteir Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $608K.
Bulldog Investors first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Bulldog Investors's Cyteir Therapeutics, Inc. Common Stock position peaked at $608K in Q4 2023.
4 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Bulldog Investors's 13F filing for Q1 2024, filed 10 May 2024.